| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Department of Diagnostic Radiology, Chonbuk National University Hospital,
Conju, Korea.
2 Department of Diagnostic Radiology, Wonkwang University School of Medicine,
Iksan, Korea.
3 Department of Diagnostic Radiology, Korean Keyryong Army Hospital, Daejeon,
Korea.
4 Department of Radiology, Seoul National University Hospital and College of
Medicine, 28, Yongon-Dong, Chongno-Gu, Seoul 110-744, Korea.
OBJECTIVE. The purpose of this study was to compare superparamagnetic iron oxide (SPIO)–enhanced MRI with gadobenate dimeglumine–enhanced MRI for the detection of hepatocellular carcinoma using receiver operating characteristic (ROC) analysis.
MATERIALS AND METHODS. Twenty-nine consecutive patients with 35 hepatocellular carcinomas underwent gadobenate dimeglumine–enhanced MRI (unenhanced, arterial, portal, and equilibrium phases) using 3D fat-saturated volumetric interpolated imaging and SPIO-enhanced MRI on a 1.5-T unit. SPIO-enhanced T2-weighted turbo spin-echo and T2*-weighted gradient-echo sequences were performed 48 hr after completion of the dynamic study. Three observers independently interpreted the images in random order, separately, and without patient identifiers. Diagnostic accuracy was evaluated using the alternative free response receiver operating characteristic method. Sensitivity and positive predictive value were also evaluated.
RESULTS. The mean sensitivity and positive predictive value of SPIO-enhanced imaging were 81.0% and 85.0%, respectively, and those of gadobenate dimeglumine–enhanced MRI were 91.4% and 88.1%, respectively. A significant difference was seen in the sensitivity of the two MRI examinations (p < 0.05). The mean value of the area under the ROC curve (Az) for gadobenate dimeglumine–enhanced imaging (Az = 0.97 ± 0.01) was significantly higher than that for SPIO-enhanced imaging (Az = 0.90 ± 0.02) (p = 0.004).
CONCLUSION. Gadobenate dimeglumine–enhanced 3D dynamic imaging showed better diagnostic performance than SPIO-enhanced imaging for the detection of hepatocellular carcinomas.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  D. T. Boll and E. M. Merkle Diffuse Liver Disease: Strategies for Hepatic CT and MR Imaging RadioGraphics, October 1, 2009; 29(6): 1591 - 1614. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y K KIM, C S KIM, and Y M HAN Detection of small hepatocellular carcinoma: comparison of conventional gadolinium-enhanced MRI with gadolinium-enhanced MRI after the administration of ferucarbotran Br. J. Radiol., June 1, 2009; 82(978): 468 - 484. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. Choi, J. M. Lee, N. C. Yu, K.-S. Suh, J.-J. Jang, S. H. Kim, and B. I. Choi Hepatocellular Carcinoma in Liver Transplantation Candidates: Detection with Gadobenate Dimeglumine-Enhanced MRI Am. J. Roentgenol., August 1, 2008; 191(2): 529 - 536. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. F. Hanna, D. A. Aguirre, N. Kased, S. C. Emery, M. R. Peterson, and C. B. Sirlin Cirrhosis-associated Hepatocellular Nodules: Correlation of Histopathologic and MR Imaging Features RadioGraphics, May 1, 2008; 28(3): 747 - 769. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. F. Hanna, N. Kased, S. W. Kwan, A. C. Gamst, A. C. Santosa, T. Hassanein, and C. B. Sirlin Double-Contrast MRI for Accurate Staging of Hepatocellular Carcinoma in Patients with Cirrhosis Am. J. Roentgenol., January 1, 2008; 190(1): 47 - 57. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. C. Lauenstein, K. Salman, R. Morreira, T. Heffron, J. R. Spivey, E. Martinez, P. Sharma, and D. R. Martin Gadolinium-Enhanced MRI for Tumor Surveillance Before Liver Transplantation: Center-Based Experience Am. J. Roentgenol., September 1, 2007; 189(3): 663 - 670. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
